Skip to main content
Download PDF

Volume 16 Supplement 1

32nd International Symposium on Intensive Care and Emergency Medicine

  • Poster presentation
  • Open access
  • Published:

Polymyxin B-immobilized fiber column hemoperfusion has the ability of endotoxin removal during 24 hours

Critical Care volume 16, Article number: P381 (2012) Cite this article

Introduction

Endotoxin plays an important role in the pathogenesis of septic shock. Endotoxin adsorption therapy by Polymyxin B-immobilized fiber column (PMX) hemoperfusion has been used for the treatment of septic shock patients in Japan. According to the company's recommendation, the standard duration of PMX treatment for patients with septic shock is 2 hours. However, we have shown that greater than 2 hours duration of PMX treatment significantly improved hemodynamics and significantly decreased administration of norepinephrine than 2 hours duration of PMX treatment. Our hypothesis was that PMX treatment had the ability of endotoxin removal during 24 hours. Therefore, the purpose of this study was to evaluate the endotoxin adsorption ability of 24 hours duration of PMX treatment.

Methods

In this study, we measured plasma endotoxin concentrations of blood drawn from the radial artery and the outlet circuit of the PMX column after 24 hours duration of PMX treatment in septic shock patients. The assay for endotoxin was performed with separated plasma from heparinized whole blood samples centrifuged at 3,000 rpm for 40 seconds. The high-sensitivity assay was performed by kinetic turbidimetric Limulus assay using a MT-358 Toxinometer (Wako Pure Chemical Industries, Ltd, Japan). This Limulus assay test is specific to endotoxin and has no cross-reaction to β-glucan. The endotoxin removal rate was defined by the equation: ((radial artery endotoxin concentration - outlet circuit of PMX column endotoxin concentration)/radial artery endotoxin concentration) × 100%. The endotoxin removal rate represents endotoxin adsorption ability. Five patients with septic shock were studied.

Results

The APACHE II scores of these patients were 26.2 ± 5.9 (mean ± SD, range 18 to 34) at admission to the ICU. Three patients survived and two patients died. Before the start of PMX treatment, heart rates were 119 ± 19 bpm, mean arterial pressures were 60 ± 19 mmHg, and plasma endotoxin concentrations of radial arterial blood were 91.4 ± 7.4 pg/ml (mean ± SD). After 24 hours duration of PMX treatment, plasma endotoxin concentrations decreased from 55.0 ± 58.9 pg/ml (radial arterial blood) to 19.4 ± 29.5 pg/ml (outlet circuit of PMX column). The endotoxin removal rate was 62.8 ± 22.1%, suggesting that endotoxin adsorption ability is still retained during 24 hours PMX treatment.

Conclusion

These findings suggest that 24 hours duration of PMX treatment is effective to remove endotoxin. Further studies are needed to confirm this ability.

References

  1. Mitaka C, et al.: Shock. 2009, 32: 478-483. 10.1097/SHK.0b013e3181a2a978

    Article  CAS  PubMed  Google Scholar 

  2. Kambayashi JJ, et al.: Biochem Biophys Methods. 1991, 22: 93-100. 10.1016/0165-022X(91)90022-O

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tokyo Medical and Dental University, Tokyo, Japan

    C Mitaka, Y Ueda, Y Miyawaki, M Yamauchi, T Toyofuku, G Haraguchi & T Kudo

Authors
  1. C Mitaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y Ueda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y Miyawaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Yamauchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T Toyofuku
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G Haraguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T Kudo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Cite this article

Mitaka, C., Ueda, Y., Miyawaki, Y. et al. Polymyxin B-immobilized fiber column hemoperfusion has the ability of endotoxin removal during 24 hours. Crit Care 16 (Suppl 1), P381 (2012). https://doi.org/10.1186/cc10988

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/cc10988

Keywords

Critical Care

ISSN: 1364-8535